Nitric oxide exerts protective effects against bleomycin-induced pulmonary fibrosis in mice
详细信息    查看全文
  • 作者:Shingo Noguchi ; Kazuhiro Yatera ; Ke-Yong Wang ; Keishi Oda…
  • 刊名:Respiratory Research
  • 出版年:2014
  • 出版时间:December 2014
  • 年:2014
  • 卷:15
  • 期:1
  • 全文大小:2,404 KB
  • 参考文献:1. Green, FH (2002) Overview of pulmonary fibrosis. Chest 122: pp. 334S-339S CrossRef
    2. Janssen, W, Pullamsetti, SS, Cooke, J, Weissmann, N, Guenther, A, Schermuly, RT (2013) The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis. J Pathol 229: pp. 242-249 CrossRef
    3. Tsutsui, M, Shimokawa, H, Morishita, T, Nakashima, Y, Yanagihara, N (2006) Development of genetically engineered mice lacking all three nitric oxide synthases. J Pharmacol Sci 102: pp. 147-154
    4. Sugiura, H, Ichinose, M (2011) Nitrative stress in inflammatory lung diseases. Nitric Oxide 25: pp. 138-144 CrossRef
    5. Ricciardolo, FL, Sterk, PJ, Gaston, B, Folkerts, G (2004) Nitric oxide in health and disease of the respiratory system. Physiol Rev 84: pp. 731-765 CrossRef
    6. Kinnula, VL, Fattman, CL, Tan, RJ, Oury, TD (2005) Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 172: pp. 417-422
    7. Saleh, D, Barnes, PJ, Giaid, A (1997) Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155: pp. 1763-1769
    8. Lakari, E, Soini, Y, S?ily, M, Koistinen, P, P??kk?, P, Kinnula, VL (2002) Inducible nitric oxide synthase, but not xanthine oxidase, is highly expressed in interstitial pneumonias and granulomatous diseases of human lung. Am J Clin Pathol 117: pp. 132-142 CrossRef
    9. Almudéver, P, Milara, J, De Diego, A, Serrano-Mollar, A, Xaubet, A, Perez-Vizcaino, F, Cogolludo, A, Cortijo, J (2013) Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis. Thorax 68: pp. 938-948 CrossRef
    10. Yoshimura, S, Nishimura, Y, Nishiuma, T, Yamashita, T, Kobayashi, K, Yokoyama, M (2006) Overexpression of nitric oxide synthase by the endothelium attenuates bleomycin-induced lung fibrosis and impairs MMP-9/TIMP-1 balance. Respirology 11: pp. 546-556 CrossRef
    11. Chung, MP, Monick, MM, Hamzeh, NY, Butler, NS, Powers, LS, Hunninghake, GW (2003) Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am J Respir Cell Mol Biol 29: pp. 375-380 CrossRef
    12. Genovese, T, Cuzzocrea, S, Di Paola, R, Failla, M, Mazzon, E, Sortino, MA, Frasca, G, Gili, E, Crimi, N, Caputi, AP, Vancheri, C (2005) Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury. Respir Res 6: pp. 58 CrossRef
    13. Hsu, YC, Wang, LF, Chien, YW (2007) Nitric oxide in the pathogenesis of diffuse pulmonary fibrosis. Free Radic Biol Med 42: pp. 599-607 CrossRef
    14. Yildirim, Z, Turkoz, Y, Kotuk, M, Armutcu, F, Gurel, A, Iraz, M, Ozen, S, Aydogdu, I, Akyol, O (2004) Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats. Nitric Oxide 11: pp. 156-165 CrossRef
    15. Davis, DW, Weidner, DA, Holian, A, McConkey, DJ (2000) Nitric oxide-dependent activation of p53 suppresses bleomycin-induced apoptosis in the lung. J Exp Med 192: pp. 857-869 CrossRef
    16. D’Alessio, FR, Tsushima, K, Aggarwal, NR, Mock, JR, Eto, Y, Garibaldi, BT, Files, DC, Avalos, CR, Rodriguez, JV, Waickman, AT, Reddy, SP, Pearse, DB, Sidhaye, VK, Hassoun, PM, Crow, MT, King, LS (2012) Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase. J Immunol 189: pp. 2234-2245
文摘
Background Increased expression of nitric oxide synthase (NOS) and an increase in plasma nitrite plus nitrate (NOx) have been reported in patients with pulmonary fibrosis, suggesting that nitric oxide (NO) plays an important role in its development. However, the roles of the entire NO and NOS system in the pathogenesis of pulmonary fibrosis still remain to be fully elucidated. The aim of the present study is to clarify the roles of NO and the NOS system in pulmonary fibrosis by using the mice lacking all three NOS isoforms. Methods Wild-type, single NOS knockout and triple NOS knockout (n/i/eNOS??/sup>) mice were administered bleomycin (BLM) intraperitoneally at a dose of 8.0?mg/kg/day for 10 consecutive days. Two weeks after the end of the procedure, the fibrotic and inflammatory changes of the lung were evaluated. In addition, we evaluated the effects of long-term treatment with isosorbide dinitrate, a NO donor, on the n/i/eNOS??/sup> mice with BLM-induced pulmonary fibrosis. Results The histopathological findings, collagen content and the total cell number in bronchoalveolar lavage fluid were the most severe/highest in the n/i/eNOS??/sup> mice. Long-term treatment with the supplemental NO donor in n/i/eNOS??/sup> mice significantly prevented the progression of the histopathological findings and the increase of the collagen content in the lungs. Conclusions These results provide the first direct evidence that a lack of all three NOS isoforms led to a deterioration of pulmonary fibrosis in a BLM-treated murine model. We speculate that the entire endogenous NO and NOS system plays an important protective role in the pathogenesis of pulmonary fibrosis.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700